Scilex Holding (SCLX) Change in Receivables (2022 - 2026)

Scilex Holding (SCLX) recorded quarterly Change in Receivables of -$4.6 million in Q1 2026, down 792.32% quarter-over-quarter from $664000.0 in Q4 2025, and up 70.95% on a YoY basis from -$2.7 million in Q1 2025.

Scilex Holding (SCLX) Change in Receivables (2022 - 2026) Analysis & Trends

Scilex Holding's Change in Receivables history runs 5 years deep, the most recent figure standing at -$4.6 million for Q1 2026.

  • In Q1 2026, Change in Receivables rose 70.95% year-over-year to -$4.6 million; the TTM figure through Mar 2026 stood at -$2.6 million (up 44.15% YoY), while the FY2025 annual figure was -$13.8 million, down 320.79% from the prior year.
  • Change in Receivables was -$4.6 million for Q1 2026 at Scilex Holding, down from $664000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $18.2 million in Q4 2023 to a low of -$15.8 million in Q1 2025.
  • Historically, Change in Receivables has averaged $480117.6 across 5 years, with a median of $664000.0 in 2025.
  • Biggest YoY gain for Change in Receivables was 1605.74% in 2023; the steepest drop was 807.75% in 2023.
  • A 5-year view of Change in Receivables shows it stood at $3.8 million in 2022, then surged by 382.96% to $18.2 million in 2023, then tumbled by 55.43% to $8.1 million in 2024, then tumbled by 91.8% to $664000.0 in 2025, then slumped by 792.32% to -$4.6 million in 2026.
  • The last three Change in Receivables figures came in at -$4.6 million (Q1 2026), $664000.0 (Q4 2025), and -$4.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Gsk 93,026,132.38 Bn 93,026,127.42 Bn 7.76 Bn -
2 Eli Lilly 1,022.62 Bn 1,017.34 Bn 16.22 Bn -
3 Johnson & Johnson 570.65 Bn 548.59 Bn 15.96 Bn 595.00 Mn
4 AbbVie 398.73 Bn 389.38 Bn 10.78 Bn -87.00 Mn
5 Merck 295.53 Bn 289.88 Bn 12.09 Bn -
6 Amgen 186.30 Bn 174.26 Bn 5.87 Bn -413.00 Mn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn -134.00 Mn
8 Pfizer 146.09 Bn 133.32 Bn -1.21 Bn -
9 Bristol Myers Squibb 114.98 Bn 104.53 Bn 8.07 Bn -1.69 Bn
10 Scilex Holding 48.31 Mn -101.62 Mn 4.15 Mn -4.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.60 Mn
Mar 31, 2026 -4.60 Mn
Dec 31, 2025 664,000.00
Dec 31, 2025 664,000.00
Sep 30, 2025 -4.83 Mn
Sep 30, 2025 -4.83 Mn
Jun 30, 2025 6.15 Mn
Jun 30, 2025 6.15 Mn
Mar 31, 2025 -15.82 Mn
Mar 31, 2025 -15.82 Mn
Dec 31, 2024 8.10 Mn
Dec 31, 2024 8.10 Mn
Sep 30, 2024 -5.24 Mn
Sep 30, 2024 -5.24 Mn
Jun 30, 2024 8.29 Mn
Jun 30, 2024 8.29 Mn
Mar 31, 2024 -4.88 Mn
Mar 31, 2024 -4.88 Mn
Dec 31, 2023 18.17 Mn
Dec 31, 2023 18.17 Mn